Posted on 07 October 2013
UCB Pharma is a global biopharma company developing treatments for diseases of the immune and central nervous system.
Posted on 22 February 2013
Abbott Laboratories announced over 130 pharma partnering / licensing deals since 2005, with over 25 deals in 2012 alone
Posted on 14 November 2011
In one of the largest partnering deals of the year, Lundbeck and Otsuka have entered into a long-term agreement for the development and commercialization of up to five innovative psychiatric and neuroscience products worldwide
Posted on 08 December 2014
Aspen Pharma, a global branded and generics pharmaceutical manufacturer, has found a place in the top 50 big pharma companies listed by Current Partnering.
Posted on 05 December 2014
Chugai Pharmaceutical manufactures, sells, imports and exports pharmaceuticals and has become the leading biopharmaceutical company in Japan.
Posted on 22 October 2014
The field of regenerative medicine is an up and coming new approach of targeting and treating diseases, it involves the repair and restoration of previously damaged tissues or organs in the body. The regenerative medicine market was worth $16bn in 2013 and industry analysts predict that this will leap to over $60bn by 2020. The more »
Posted on 10 October 2014
Nektar Therapeutics is a leading biopharma company developing clinical stage products based upon its advanced polymer conjugate chemistry technology.
Posted on 09 October 2014
The partnering and M&A trends and deal analysis of the top 50 pharma and biotech companies reveals a flurry of data that is interesting to observe for efficient deal making.
Posted on 08 October 2014
The bioinformatics partnering deal trend analysis 2009 to 2014 are reviewed in this article.
Posted on 29 September 2014
Genmab, a top big biotech company, headquartered in Denmark is one of the leaders today in the human antibody therapeutics market for cancer treatment.